Sign up
Log in
12 Health Care Stocks Moving In Wednesday's After-Market Session
Share
Listen to the news

Gainers

  • Protagenic Therapeutics (NASDAQ:PTIX) stock moved upwards by 151.6% to $0.57 during Wednesday's after-market session. The market value of their outstanding shares is at $4.1 million. As per the press release, Q4 earnings came out 2 days ago.
  • Aptevo Therapeutics (NASDAQ:APVO) stock rose 32.6% to $1.83. The company's market cap stands at $2.6 million.
  • Genprex (NASDAQ:GNPX) shares moved upwards by 32.16% to $0.39. The company's market cap stands at $3.3 million.
  • Klotho Neurosciences (NASDAQ:KLTO) stock rose 12.66% to $0.23. The company's market cap stands at $6.1 million. As per the news, the Q4 earnings report came out 2 days ago.
  • Oragenics (AMEX:OGEN) stock rose 10.2% to $0.22. The market value of their outstanding shares is at $4.7 million.
  • Biodesix (NASDAQ:BDSX) stock moved upwards by 9.92% to $0.69. The market value of their outstanding shares is at $100.1 million.

Losers

  • bioAffinity Technologies (NASDAQ:BIAF) stock declined by 21.1% to $0.7 during Wednesday's after-market session. The market value of their outstanding shares is at $10.9 million. As per the news, the Q4 earnings report came out 2 days ago.
  • Twist Bioscience (NASDAQ:TWST) shares declined by 16.27% to $32.0. The company's market cap stands at $1.9 billion.
  • Adaptive Biotechnologies (NASDAQ:ADPT) shares decreased by 13.73% to $6.85. The company's market cap stands at $1.0 billion.
  • Cerus (NASDAQ:CERS) stock decreased by 12.86% to $1.22. The company's market cap stands at $226.6 million.
  • Citius Oncology (NASDAQ:CTOR) shares decreased by 12.08% to $0.7. The market value of their outstanding shares is at $50.3 million.
  • Biodexa Pharmaceuticals (NASDAQ:BDRX) shares fell 11.04% to $1.37. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending
No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.